New cancer clinical trial: Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)

Published on: February 08, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share